Continuous Flow Reactors That Make a Difference
Commercial-ready flow technology for real manufacturing
Fill the Flow Readiness QuestionnaireDesigned for industry, not just laboratories
Our continuous flow reactors are engineered and proven for full commercial manufacturing, with capacity up to 200,000 TPA. Designed for high throughput, long-duration operation, and industrial reliability.
Continuous flow processing ensures lower reactive inventory, superior temperature and pressure control, and rapid heat removal—delivering a significantly safer alternative to batch processing, especially for hazardous and highly exothermic reactions.
With over 150 commercial installations, our flow reactors are operating successfully across fine chemicals, agrochemicals, pharmaceuticals, and specialty chemicals—demonstrating reliability, scalability, and industry trust.
Backed by 30+ patents, our reactor technologies reflect deep, original innovation in reactor design, multiphase handling, and process intensification—protecting real, commercially deployed advantages.
For more than 15 years, we have worked solely on continuous flow reactors—from R&D to full-scale installations—ensuring unmatched expertise, faster execution, and lower project risk.
From Paper to Market — We support your project at every stage—feasibility, process development, piloting, engineering, installation, and commissioning—ensuring a smooth, low-risk transition from concept to commercial production.
One partner from concept to commercialisation
Developed with our proven technology collaborators
Widest reactor portfolio in the market
From hazardous to high-value reactions
Measured manufacturing impact
Better control. Better outcomes.
No more batch failures
Targeted selectivity
Higher conversion & yield
Tight temperature & pressure control
Minimal impurity formation
Lower dependence on skilled manpower
Name |
Contact Number |
|
|---|---|---|
| Dr Sanjay Loomba | +91 8121007791 | sanjay@rifapharma.com |
| Pavan Bellamkonda | +91 7680956327 | bizdevelop@rifapharma.com |
Get the latest insights, technology news, and case studies.
Estimate savings and operational efficiencies with continuous flow.
Go to calculator
Mumbai
Hyderabad
China
Vapi, Gujarat(Warehouse)
+91 9619494942
+91 9702958555
+91 9987776776
Copyright 2022 Rifa Pharma | Designed and Developed By Enliten IT
Connect with our Medical Devices Specialist for product guidance, technical support, and partnership inquiries.
|
Name |
Contact Number |
|
|---|---|---|
| Disha Desai | +91 96194 94942 | disha.desai@rifapharma.com |
Ms. Desai has masterfully elevated the valuation of the Packaging and Medical Devices division, breaking barriers and unlocking new opportunities. She is an invaluable force with over 10+ years of expertise and a portfolio of 30+ customer companies. Her relentless hustle, strategic vision, and unwavering determination not only seize opportunities but create them, driving unprecedented growth and success.
Ms. Ujwala is a razor-sharp professional with an unwavering focus on delivering results. With deep expertise in the veterinary premix market, she ensures every promise and goal is achieved. Her tenacity, proficiency with active ingredients, and strategic foresight set her apart. Leading sales and new developments at Rifa Pharma, she drives innovation, sustainability, and impactful growth, making her a trusted advisor and partner in success.
Our CEO and partner - Dr. Sanjay Loomba, a trauma surgeon and visionary leader, brings over 18 years of expertise in healthcare and the pharmaceutical industry. He has been instrumental in establishing advanced manufacturing facilities and optimising procurement for global markets. Currently, at Rifa Pharma, he focuses on driving innovation, enhancing operational excellence, promoting sustainability, and delivering patient-centric solutions that address the evolving needs of the healthcare sector.
Neha is a dynamic and accomplished leader at Rifa Pharma, bringing over 25 years of expertise in the pharmaceutical industry, with a strong focus on operations. She is highly proficient in business development and regulatory affairs, successfully securing global approvals and driving impactful market expansion. As the Vice Chairperson of the IDMA Bulk Drug Committee, she plays a pivotal role in enhancing industry influence. Her comprehensive expertise extends across corporate governance, ESG strategy, and stakeholder engagement, ensuring sustainable growth and unwavering compliance excellence..
Anant Thakore embodies resilience, vision, and leadership.Stepping in during a critical phase, he revolutionized the company,driving it to a remarkable $60 million indenting enterprise.A true pioneer in India’s pharmaceutical landscape,he played a crucial role in advancing anti-tuberculosis and antibiotic manufacturing. His groundbreaking achievements include becoming the first indigenous manufacturer of corticosteroids,solidifying his legacy as a transformative force in the industry.
